1 Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima; and Department of Neurosurgery, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
The increase in the incidental detection of asymptomatic pituitary adenomas, known as “pituitary inciden-talomas,” led the authors to conduct a survey of the natural course of these lesions.
Forty-two patients with clinically nonfunctioning pituitary adenomas who had manifested no neurological or endocrinological disorders were monitored with magnetic resonance imaging studies. The follow-up period ranged from 10.8 to 168.2 months (mean ± standard deviation, 61.9 ± 38.2 months). The mean initial tumor size was 18.3 ± 7 mm.
In 21 patients, the tumor increased by at least 10% of its measured size on detection. This increase was first detected between 8.4 and 58.8 months (mean 31.8 ± 17.6 months) after diagnosis. There was no correlation between the original tumor size, patient age, or the presence of intratumoral cysts and tumor growth. Symptoms were noted in 10 patients during follow up; in four, extensive tumor necrosis accompanied hemorrhage, leading to severe headache, acute ophthalmological symptoms, and panhypopituitarism, which was indicative of pituitary apoplexy. Transsphenoidal surgery was performed in 12 patients with enlarged tumors, including three with apoplexy. With the exception of one apoplectic patient, visual function was recovered in all who underwent surgery. All apoplectic patients continue to manifest hypopituitarism.
In the course of 4 years, the size of the incidentalomas increased in 40% of 42 patients and became symptomatic in 20%. During the 5-year follow up, pituitary apoplexy developed in 9.5%. These findings may justify early intervention, especially in young individuals with incidentally found macroadenoma.
Abbreviations used in this paper:LHRH = luteinizing hormone–releasing hormone; MR = magnetic resonance; TSS = transsphenoidal surgery.
Address reprint requests to: Kazunori Arita, M.D., Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1, Sakuragoaka, Kagoshima, 890-8520, Japan. email:
FeldkampJSantenRHarmsEAulichAModderUScherbaumWA: Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas—results of a prospective study. Clin Endocrinol (Oxf)51:109–1131999
SumidaMUozumiTYamanakaMMukadaKAritaKKurisuK: Displacement of the normal pituitary gland by sellar and juxtasellar tumors: surgical-MRI correlation and use in differential diagnosis. Neuroradiology36:372–3751994
TanakaYHongoKTadaTSakaiKKakizawaYKobayashiS: Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg98:359–3652003
YueNCLongstrethWTJrElsterADJungreisCAO’LearyDHPoirierVC: Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology202:41–461997